Advertisement
SALT LAKE CITY and BOSTON, May 11, 2011 /PRNewswire/ -- The Forum on Personalized Health Care today announced the official launch of The Roadmap for Personalized Health Care, an actionable primary roadmap for the development of precision, personalized health care.
Led by Harvard Business School professor Clayton Christensen, creator of the theory of disruptive innovation, and Forum executive director Kimball Thomson, the Roadmap will draw from and build upon Christensen's analysis of how disruptive forces can be put to work to help effect systemic change in diagnosis and patient care. It will also incorporate the analysis and hands-on experience of PwC, Leavitt Partners and other key industry collaborators in accelerating, aligning and coordinating efforts to improve the efficacy and cost-effectiveness of patient diagnosis and care.
"There is no industry sector more in need of disruptive innovation than health care," said Clayton Christensen of Harvard Business School, and co-leader of The Roadmap for Personalized Health Care. "By identifying the most fruitful questions and how best to address them, The Roadmap will be a key catalyst for shaping the future direction of health care in the U.S. and globally."
The Roadmap will guide the development and utilization of transformative technologies, business models and value networks that increase the effectiveness of care and reduce costs of health care delivery. It is designed to provide stakeholders in the health care community — including patients, researchers, vendors, doctors, payers, investors, and community and government leaders — with an actionable plan to guide and influence the community's efforts in a coordinated manner to maximize returns on effort, encourage the pooling of resources, and eliminate zero-sum competition.
"Personalized health care holds the promise for new, more effective diagnosis and treatment regimens and a higher level of proactive patient participation, but will depend on new paradigms for collaboration, reimbursement, regulatory guidance, new market participants and alternative business models," said Gerry McDougall, head of Personalized Healthcare and Health Sciences practices for PwC. "The capacity to innovate is not only a transformative opportunity for the health system, but an imperative for the nation's economic growth and international competitiveness. It will require the coordinated efforts of the most forward-thinking leaders in industry, government, education and research."
Myriad regulations and their web of unintended consequences have created significant roadblocks to disruptive innovation. To engineer solutions for overcoming these obstacles, the creators of the Roadmap are engaged in an active collaboration with members of Congress. Leaders on both sides of the aisle have enlisted the support of the Forum and offered direct support for the creation and utilization of the Roadmap to effect enlightened and informed bi-partisan policy and oversight.
"Advances in personalized health care through innovative research will result in new technologies that change the way we practice medicine," said U.S. Senator Orrin Hatch. "These new advances will have the power to revolutionize the way we prevent, diagnose and treat diseases, thus benefiting millions of consumers and patients. The promise of personalized medicine transcends politics, and I sincerely hope that we can all work together to unlock its true potential."
Oversight for The Roadmap on Personalized Health Care will be provided by the global health care luminaries on The Forum on Personalized Health Care board of directors:
The Forum on Personalized Health Care (www.personalizedhealthcaresummit.org) is a non-profit collaborative community created to accelerate the development and utilization of transformative science, technologies and health care delivery approaches that improve patient care, reduce health care costs and increase patient engagement. The Forum's premier annual event, The National Summit on Personalized Health Care, brings together top leaders from industry, government and higher education to create executable action plans to fulfill the Forum's core mission.
Contact:Kimball ThomsonThe Forum on Personalized Health [email protected]
SOURCE Forum on Personalized Health Care
Advertisement
Led by Harvard Business School professor Clayton Christensen, creator of the theory of disruptive innovation, and Forum executive director Kimball Thomson, the Roadmap will draw from and build upon Christensen's analysis of how disruptive forces can be put to work to help effect systemic change in diagnosis and patient care. It will also incorporate the analysis and hands-on experience of PwC, Leavitt Partners and other key industry collaborators in accelerating, aligning and coordinating efforts to improve the efficacy and cost-effectiveness of patient diagnosis and care.
"There is no industry sector more in need of disruptive innovation than health care," said Clayton Christensen of Harvard Business School, and co-leader of The Roadmap for Personalized Health Care. "By identifying the most fruitful questions and how best to address them, The Roadmap will be a key catalyst for shaping the future direction of health care in the U.S. and globally."
The Roadmap will guide the development and utilization of transformative technologies, business models and value networks that increase the effectiveness of care and reduce costs of health care delivery. It is designed to provide stakeholders in the health care community — including patients, researchers, vendors, doctors, payers, investors, and community and government leaders — with an actionable plan to guide and influence the community's efforts in a coordinated manner to maximize returns on effort, encourage the pooling of resources, and eliminate zero-sum competition.
"Personalized health care holds the promise for new, more effective diagnosis and treatment regimens and a higher level of proactive patient participation, but will depend on new paradigms for collaboration, reimbursement, regulatory guidance, new market participants and alternative business models," said Gerry McDougall, head of Personalized Healthcare and Health Sciences practices for PwC. "The capacity to innovate is not only a transformative opportunity for the health system, but an imperative for the nation's economic growth and international competitiveness. It will require the coordinated efforts of the most forward-thinking leaders in industry, government, education and research."
Myriad regulations and their web of unintended consequences have created significant roadblocks to disruptive innovation. To engineer solutions for overcoming these obstacles, the creators of the Roadmap are engaged in an active collaboration with members of Congress. Leaders on both sides of the aisle have enlisted the support of the Forum and offered direct support for the creation and utilization of the Roadmap to effect enlightened and informed bi-partisan policy and oversight.
"Advances in personalized health care through innovative research will result in new technologies that change the way we practice medicine," said U.S. Senator Orrin Hatch. "These new advances will have the power to revolutionize the way we prevent, diagnose and treat diseases, thus benefiting millions of consumers and patients. The promise of personalized medicine transcends politics, and I sincerely hope that we can all work together to unlock its true potential."
Oversight for The Roadmap on Personalized Health Care will be provided by the global health care luminaries on The Forum on Personalized Health Care board of directors:
- Mara Aspinall, founder and director, On-Q-ity
- G. Steven Burrill, CEO of Burrill & Company
- Clayton Christensen, Harvard Business School
- Leroy Hood, CEO, Institute for Systems Biology
- Clay Marsh, executive director, The Ohio State University's Center for Personalized Health Care
- Michael O. Leavitt, CEO, Leavitt Partners, former Utah Governor and HHS Secretary
- Ralph Snyderman, Chancellor Emeritus; Duke University; founder and chair, Proventys
- Risa Stack, partner, Kleiner Perkins Caufield & Byers
- Kimball Thomson, executive director, The Forum on Personalized Health Care
- Eric Topol, chief academic officer, Scripps Health; director, Scripps Translational Science Institute.
The Forum on Personalized Health Care (www.personalizedhealthcaresummit.org) is a non-profit collaborative community created to accelerate the development and utilization of transformative science, technologies and health care delivery approaches that improve patient care, reduce health care costs and increase patient engagement. The Forum's premier annual event, The National Summit on Personalized Health Care, brings together top leaders from industry, government and higher education to create executable action plans to fulfill the Forum's core mission.
Contact:Kimball ThomsonThe Forum on Personalized Health [email protected]
SOURCE Forum on Personalized Health Care
